Clinical Trials Corner: Nephrectomy in the New Year.
- Published in:
- Kidney Cancer (2468-4562), 2022, v. 6, n. 1, p. 81, doi. 10.3233/KCA-229001
- By:
- Publication type:
- Article
Works matching IS 24684562 AND DT 2022 AND VI 6 AND IP 1
Results: 8
1
2
In Memoriam: Chris Wood.
- Published in:
- 2022
- By:
- Publication type:
- Obituary
3
Comparative Evaluation of Safety and Efficacy of Alternate Schedule (AS) of Sunitinib in Asian and Non-Asian Patient Population for the Treatment of Metastatic Renal Cell Cancer (mRCC): A Meta-Analysis.
- Published in:
- Kidney Cancer (2468-4562), 2022, v. 6, n. 1, p. 37, doi. 10.3233/KCA-210122
- By:
- Publication type:
- Article
4
Extended Disease Control with Unconventional Cabozantinib Dose Increase in Metastatic Renal Cell Carcinoma.
- Published in:
- Kidney Cancer (2468-4562), 2022, v. 6, n. 1, p. 69, doi. 10.3233/KCA-210117
- By:
- Publication type:
- Article
5
Patient-Derived Renal Cell Carcinoma Xenografts Capture Tumor Genetic Profiles and Aggressive Behaviors.
- Published in:
- Kidney Cancer (2468-4562), 2022, v. 6, n. 1, p. 11, doi. 10.3233/KCA-210011
- By:
- Publication type:
- Article
6
"PROBE"ing the Role of Cytoreductive Nephrectomy in Advanced Renal Cancer.
- Published in:
- Kidney Cancer (2468-4562), 2022, v. 6, n. 1, p. 3, doi. 10.3233/KCA-210010
- By:
- Publication type:
- Article
7
BRCA1-Associated Protein 1 (BAP-1) as a Prognostic and Predictive Biomarker in Clear Cell Renal Cell Carcinoma: A Systematic Review.
- Published in:
- Kidney Cancer (2468-4562), 2022, v. 6, n. 1, p. 23, doi. 10.3233/KCA-210006
- By:
- Publication type:
- Article
8
Systematic Review of Treatment of Metastatic Non-Clear Cell Renal Cell Carcinoma.
- Published in:
- Kidney Cancer (2468-4562), 2022, v. 6, n. 1, p. 53, doi. 10.3233/KCA-210005
- By:
- Publication type:
- Article